Heidrun Ullrich

741 total citations
22 papers, 586 citations indexed

About

Heidrun Ullrich is a scholar working on Immunology, Surgery and Hematology. According to data from OpenAlex, Heidrun Ullrich has authored 22 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Surgery and 5 papers in Hematology. Recurrent topics in Heidrun Ullrich's work include Lipoproteins and Cardiovascular Health (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Acute Myeloid Leukemia Research (2 papers). Heidrun Ullrich is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Acute Myeloid Leukemia Research (2 papers). Heidrun Ullrich collaborates with scholars based in Germany, Austria and United States. Heidrun Ullrich's co-authors include Gerd Schmitz, Stefan W. Krause, Reinhard Andreesen, Karin Pfister, Gabriele Multhoff, Catharina C. Groß, Robert Gastpar, Karl J. Lackner, Christa Buechler and Charalampos Aslanidis and has published in prestigious journals such as Blood, Clinical Cancer Research and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Heidrun Ullrich

22 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidrun Ullrich Germany 12 249 170 126 100 78 22 586
Andreas R. Huber Switzerland 4 383 1.5× 164 1.0× 126 1.0× 80 0.8× 67 0.9× 8 725
A. Wölpl Germany 9 345 1.4× 168 1.0× 82 0.7× 53 0.5× 69 0.9× 31 616
Yuji Tsuruta Japan 16 347 1.4× 216 1.3× 162 1.3× 101 1.0× 132 1.7× 34 954
V. Barak Israel 13 218 0.9× 206 1.2× 88 0.7× 79 0.8× 40 0.5× 28 774
Valentina Bevelacqua Italy 13 269 1.1× 258 1.5× 228 1.8× 80 0.8× 53 0.7× 22 743
Elahe Crockett-Torabi United States 11 338 1.4× 196 1.2× 75 0.6× 52 0.5× 89 1.1× 12 666
Minoru Sasano Japan 15 317 1.3× 234 1.4× 129 1.0× 53 0.5× 92 1.2× 48 918
Barbara D. Summers United States 13 131 0.5× 158 0.9× 48 0.4× 118 1.2× 76 1.0× 20 565
Jieru Geng United States 10 186 0.7× 297 1.7× 79 0.6× 59 0.6× 112 1.4× 15 805
Richard D. Maca United States 15 273 1.1× 207 1.2× 131 1.0× 53 0.5× 53 0.7× 33 722

Countries citing papers authored by Heidrun Ullrich

Since Specialization
Citations

This map shows the geographic impact of Heidrun Ullrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidrun Ullrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidrun Ullrich more than expected).

Fields of papers citing papers by Heidrun Ullrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidrun Ullrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidrun Ullrich. The network helps show where Heidrun Ullrich may publish in the future.

Co-authorship network of co-authors of Heidrun Ullrich

This figure shows the co-authorship network connecting the top 25 collaborators of Heidrun Ullrich. A scholar is included among the top collaborators of Heidrun Ullrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidrun Ullrich. Heidrun Ullrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ullrich, Heidrun, Roland A. Fischer, Regine Grosse, et al.. (2008). Erythrocytapheresis: Do Not Forget a Useful Therapy!. Transfusion Medicine and Hemotherapy. 35(1). 24–30. 9 indexed citations
2.
Sargent, Carole A., Michael Duszenko, D. Gareth Evans, et al.. (2005). Microarray analysis of gene expression under in vitro growth conditions mimicking the in vivo environment. Veterinary Microbiology. 110(3-4). 255–263. 36 indexed citations
3.
Ullrich, Heidrun & P. Kuehnl. (2004). New trends in specific immunoadsorption. Transfusion and Apheresis Science. 30(3). 223–231. 11 indexed citations
4.
Ullrich, Heidrun, Tobias Kleinjung, Thomas Steffens, et al.. (2004). Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. Journal of Clinical Apheresis. 19(2). 71–78. 38 indexed citations
5.
Krause, Stefan W., Robert Gastpar, Reinhard Andreesen, et al.. (2004). Treatment of Colon and Lung Cancer Patients withex VivoHeat Shock Protein 70-Peptide-Activated, Autologous Natural Killer Cells. Clinical Cancer Research. 10(11). 3699–3707. 202 indexed citations
7.
Buechler, Christa, Heidrun Ullrich, Charalampos Aslanidis, et al.. (2003). Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1642(1-2). 25–31. 38 indexed citations
8.
Ullrich, Heidrun, Wolfgang Jakob, Dieter Fröhlich, et al.. (2001). A New Endotoxin Adsorber: First Clinical Application. Therapeutic Apheresis. 5(5). 326–334. 22 indexed citations
9.
Buechler, Christa, Heidrun Ullrich, Mirko Ritter, et al.. (2001). Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes. Blood. 97(4). 981–986. 51 indexed citations
10.
Reichle, Albrecht, G. Rothe, Stefan W. Krause, et al.. (1999). Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia. Leukemia. 13(8). 1227–1234. 13 indexed citations
11.
Ullrich, Heidrun, Karl J. Lackner, & Gerd Schmitz. (1998). Lipoprotein(a) Apheresis in Severe Coronary Heart Disease: an Immunoadsorption Method. Artificial Organs. 22(2). 135–139. 14 indexed citations
12.
Langmann, Thomas, et al.. (1997). Structural organization and characterization of the promoter region of a human carboxylesterase gene. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1350(1). 65–74. 37 indexed citations
13.
Ullrich, Heidrun, et al.. (1997). Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Superiority of Protein A Immunoadsorption over Plasma Exchange Treatment. Transfusion Science. 19. 33–38. 9 indexed citations
14.
Ullrich, Heidrun, et al.. (1997). [Effect of processed blood volume, leukocyte count and concentration of CD34-positive cells in peripheral blood on efficiency of stem cell apheresis].. PubMed. 34. 139–43. 2 indexed citations
15.
Ullrich, Heidrun, K Lackner, & Gerd Schmitz. (1996). Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease. Transfusion Science. 17(4). 511–517. 11 indexed citations
16.
Ullrich, Heidrun. (1996). Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease. Transfusion Science. 17(4). 511–517. 5 indexed citations
17.
Ullrich, Heidrun, et al.. (1995). Treatment of severe localized scleroderma by plasmapheresis report of three cases. British Journal of Dermatology. 133(4). 605–609. 16 indexed citations
18.
Weinstock, Christof, Heidrun Ullrich, Aloys Berg, et al.. (1992). Low density lipoproteins inhibit endotoxin activation of monocytes.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(3). 341–347. 37 indexed citations
19.
Schäd, Susanne G., et al.. (1992). [Rheologic studies before and after therapeutic cytapheresis and plasma exchange treatment].. PubMed. 30. 301–5. 2 indexed citations
20.
Ullrich, Heidrun, et al.. (1992). [Therapeutic thrombocytapheresis in patients with myeloproliferative diseases with the cell separators Fresenius AS 104 and Cobe Spectra: biocompatibility and safety].. PubMed. 30. 311–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026